ConductScience.org, home
PRAME: PRAME nuclear receptor transcriptional regulator
API referenceFor AI assistants

Gene · 23532

Papers1,874

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,874

Download this page as JSON
TitleJournalYearPMIDFound bySource
Molecular Characterization of Sclerosing Nevi With Pseudomelanomatous Features.J Cutan Pathol202642816143PubTator, text miningPubMed
Papillary endothelial hyperplasia in late post-radiation or late post-operative breast hematomas mimicking angiosarcoma.Hum Pathol202642815784PubTator, text miningPubMed
Search for leukemia-restricted targets: a new paradigm for precision immunotherapy in acute myeloid leukemia.Haematologica202642779343PubTator, text miningPubMed
Immunohistochemical Predictors in Head and Neck Mucosal Melanoma.Head Neck Pathol202642771296PubTator, text miningPubMed
PRAME as a Diagnostic Adjunct in Clear Cell Sarcoma.Appl Immunohistochem Mol Morphol202642746728PubTator, text miningPubMed
Performance of PRAME Immunohistochemistry in Distinguishing Classic Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma and T-Cell Lymphoma.Cancers (Basel)202642738395PubTator, text miningPubMed
Top advances of the year in autologous cellular therapy in melanoma and solid tumors.Cancer202642734903PubTator, text miningPubMed
Histopathologic, Genomic, and Clinical Characteristics of Primary Cutaneous Melanocytic Tumors With Concomitant NRAS Q61 and IDH1 R132C Mutations.Mod Pathol202642710739PubTator, text miningPubMed
Sentinel lymph node biopsy in melanoma: pathologic evaluation and diagnostic considerations.J Pathol Transl Med202642675997PubTator, text miningPubMed
Integrated Immunotherapy Target Atlas for Ewing Sarcoma.Cancer Genomics Proteomics202642674817PubTator, text miningPubMed
Malignant MITF-Rearranged PEComa With Novel EEF1A1::MITF Fusion.Genes Chromosomes Cancer202642671146PubTator, text miningPubMed
PRAME promotes invasion and metastasis of salivary adenoid cystic carcinoma by regulating RARα stability via the cullin2 ubiquitin-proteasome system.Clin Transl Med202642660821PubTator, text miningPubMed
Quantifying the Interplay Between PRAME Expression and Classical Morphology: A Multivariable Analysis of 954 Suspected Melanocytic Lesions.Dermatopathology (Basel)202642647382PubTator, text miningPubMed
PRAME Expression in Merkel Cell Carcinoma: Correlation With MCPyV Status, PD-L1, and Tumor-Infiltrating Lymphocytes in a Multicenter Cohort.Appl Immunohistochem Mol Morphol202642640597PubTator, text miningPubMed
Histopathology and Clinical Features of SPARK Nevi in a Multi-Institutional Cohort.Int J Surg Pathol202642599278PubTator, text miningPubMed
PRAME-Specific T-Cell Therapy in Advanced Pediatric Nephroblastoma.N Engl J Med202642585654PubTator, text miningPubMed
Prognostic testing in Brazilian patients with uveal melanoma using 15-gene expression profile and preferentially expressed antigen in melanoma.Arq Bras Oftalmol202642561320PubTator, text miningPubMed
Advances in the multimodal management of central nervous system solitary fibrous tumors.Front Oncol202642518808PubTator, text miningPubMed
The evolution of cellular therapies in sarcoma: Breakthroughs, challenges, and future directions.Hum Vaccin Immunother202642517272PubTator, text miningPubMed
Characterization of preferentially expressed antigen in melanoma (PRAME) expression in pigmented actinic keratoses and pigmented squamous cell carcinomas in situ.JAAD Int202642499355PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/23532/papers

API referenceFor AI assistants